CVS · 8-K · 20260805PR000097
Litigation and Legal Risk
CVS HEALTH Corp · 2026-08-05 · Importance 28 · Surprise 42 · In source text
CVS Health reported that the prior-year quarter included $833 million of legacy litigation charges related to two court decisions involving past business practices. The charges affected the Health Services and Pharmacy & Consumer Wellness segments, including $291 million and $542 million, respectively, in the three months ended June 30, 2025. For the six months ended June 30, 2025, legacy litigation charges totaled $1.220 billion, while no comparable charge was recorded in the first half of 2026.
Key facts
- For Q2 2026, operating income increased 97.5% primarily due to increased adjusted operating income and absence of $833 million in legacy litigation charges recorded in prior year source
- Company recorded absence of legacy litigation charges of $833 million in prior year Q2 2025 (legacy litigation charges were recorded in Q2 2025) source
- During three and six months ended June 30, 2025, legacy litigation charges related to two court decisions were recorded and were reflected in operating expenses within Pharmacy & Consumer Wellness and Health Services segments source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| operating_income | positive | realized | +0.8% | For Q2 2026, operating income increased 97.5% primarily due to increased adjusted operating income and absence of $833 million in legacy… |